長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4592】サンバイオ

【4592】サンバイオ
再生細胞薬を開発。
類似企業：
【業界1位】 小野薬品工業


東証グロース
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2027.01 2026/09/14 Q2予 396 → 0.0% 0.0% -5,229 → 0.0% +7.0% -5,074 → 0.0% +9.9% -5,133 → 0.0% +8.9%
2027.01 2026/06/15 Q1予 396 → 0.0% 0.0% -5,229 → 0.0% +7.0% -5,074 → 0.0% +9.9% -5,133 → 0.0% +8.9%
2027.01 2026/05/13 修正予 396 - - - -5,229 ↑ +7.0% +7.0% -5,074 ↑ +9.9% +9.9% -5,133 ↑ +8.9% +8.9%
2027.01 2026/03/17 当初予 - - - - -5,625 - - - -5,632 - - - -5,635 - - -
2026.01 2026/03/17 実 0 - - - -3,794 ↑ +3.2% -8.1% -4,291 ↑ +5.3% -20.8% -3,842 ↑ +5.0% -8.1%
2026.01 2025/12/15 Q3予 - - - - -3,920 → 0.0% -11.7% -4,530 → 0.0% -27.6% -4,045 → 0.0% -13.8%
2026.01 2025/09/12 Q2予 - - - - -3,920 ↓ -11.7% -11.7% -4,530 ↓ -27.6% -27.6% -4,045 ↓ -13.8% -13.8%
2026.01 2025/06/13 Q1予 - - - - -3,509 → 0.0% 0.0% -3,551 → 0.0% 0.0% -3,554 → 0.0% 0.0%
2026.01 2025/03/17 当初予 - - - - -3,509 - - - -3,551 - - - -3,554 - - -
2025.01 2025/03/17 実 0 → - - -3,516 ↓ -5.3% -5.3% -3,022 ↓ -10.5% +10.0% -2,882 ↓ -5.3% +14.2%
2025.01 2025/02/04 修正予 0 - - - -3,339 → 0.0% 0.0% -2,736 ↑ +18.5% +18.5% -2,736 ↑ +18.5% +18.5%
2025.01 2024/12/16 Q3予 - - - - -3,339 → 0.0% 0.0% -3,359 → 0.0% 0.0% -3,359 → 0.0% 0.0%
2025.01 2024/09/17 Q2予 - - - - -3,339 → 0.0% 0.0% -3,359 → 0.0% 0.0% -3,359 → 0.0% 0.0%
2025.01 2024/06/13 Q1予 - - - - -3,339 → 0.0% 0.0% -3,359 → 0.0% 0.0% -3,359 → 0.0% 0.0%
2025.01 2024/03/18 当初予 - - - - -3,339 - - - -3,359 - - - -3,359 - - -
2024.01 2024/03/18 実 0 - - - -4,539 ↑ +2.2% +2.2% -2,824 ↑ +38.6% +38.6% -2,644 ↑ +42.5% +42.5%
2024.01 2023/12/14 Q3予 - - - - -4,642 → 0.0% 0.0% -4,597 → 0.0% 0.0% -4,598 → 0.0% 0.0%
2024.01 2023/09/14 Q2予 - - - - -4,642 → 0.0% 0.0% -4,597 → 0.0% 0.0% -4,598 → 0.0% 0.0%
2024.01 2023/06/14 Q1予 - - - - -4,642 → 0.0% 0.0% -4,597 → 0.0% 0.0% -4,598 → 0.0% 0.0%
2024.01 2023/03/16 当初予 - - - - -4,642 - - - -4,597 - - - -4,598 - - -
2023.01 2023/03/16 実 0 - - - -7,899 ↑ +2.9% -34.8% -4,698 ↓ -9.3% +21.6% -5,559 ↑ +2.2% +7.3%
2023.01 2022/12/15 Q3予 - - - - -8,131 → 0.0% -38.8% -4,298 → 0.0% +28.3% -5,684 → 0.0% +5.2%
2023.01 2022/09/14 Q2予 - - - - -8,131 ↓ -38.8% -38.8% -4,298 ↑ +28.3% +28.3% -5,684 ↑ +5.2% +5.2%
2023.01 2022/06/14 Q1予 - - - - -5,858 → 0.0% 0.0% -5,991 → 0.0% 0.0% -5,997 → 0.0% 0.0%
2023.01 2022/03/11 当初予 - - - - -5,858 - - - -5,991 - - - -5,997 - - -
2022.01 2022/03/11 実 0 - - - -6,620 ↓ -14.4% -14.4% -4,579 ↑ +22.1% +22.1% -4,677 ↑ +20.4% +20.4%
2022.01 2021/12/15 Q3予 - - - - -5,786 → 0.0% 0.0% -5,876 → 0.0% 0.0% -5,877 → 0.0% 0.0%
2022.01 2021/09/14 Q2予 - - - - -5,786 → 0.0% 0.0% -5,876 → 0.0% 0.0% -5,877 → 0.0% 0.0%
2022.01 2021/06/14 Q1予 - - - - -5,786 → 0.0% 0.0% -5,876 → 0.0% 0.0% -5,877 → 0.0% 0.0%
2022.01 2021/03/17 当初予 - - - - -5,786 - - - -5,876 - - - -5,877 - - -
2021.01 2021/03/17 実 0 → - - -5,801 ↓ -0.7% -6.4% -6,530 ↓ -0.6% -17.8% -3,385 ↓ -0.7% +38.9%
2021.01 2021/02/25 修正予 0 - - - -5,761 ↓ -5.6% -5.6% -6,490 ↓ -17.1% -17.1% -3,363 ↑ +39.3% +39.3%
2021.01 2020/12/15 Q3予 - - - - -5,453 → 0.0% 0.0% -5,543 → 0.0% 0.0% -5,544 → 0.0% 0.0%
2021.01 2020/09/14 Q2予 - - - - -5,453 → 0.0% 0.0% -5,543 → 0.0% 0.0% -5,544 → 0.0% 0.0%
2021.01 2020/06/12 Q1予 - - - - -5,453 → 0.0% 0.0% -5,543 → 0.0% 0.0% -5,544 → 0.0% 0.0%
2021.01 2020/03/16 当初予 - - - - -5,453 - - - -5,543 - - - -5,544 - - -
2020.01 2020/03/16 実 447 → 0.0% -37.3% -5,486 ↓ -7.8% +6.8% -5,146 ↓ -11.5% +4.5% -5,157 ↓ -11.6% +4.4%
2020.01 2019/12/13 修正予 447 ↓ -37.3% -37.3% -5,088 ↑ +13.6% +13.6% -4,617 ↑ +14.3% +14.3% -4,619 ↑ +14.4% +14.4%
2020.01 2019/09/13 Q2予 713 → 0.0% 0.0% -5,887 → 0.0% 0.0% -5,390 → 0.0% 0.0% -5,395 → 0.0% 0.0%
2020.01 2019/06/14 Q1予 713 → 0.0% 0.0% -5,887 → 0.0% 0.0% -5,390 → 0.0% 0.0% -5,395 → 0.0% 0.0%
2020.01 2019/03/15 当初予 713 - - - -5,887 - - - -5,390 - - - -5,395 - - -
2019.01 2019/03/15 実 741 ↓ -0.1% -27.7% -3,733 ↑ +3.8% -5.5% -2,919 ↑ +1.8% -15.4% -2,920 ↑ +1.9% -13.9%
2019.01 2019/01/28 修正予 742 ↓ -27.6% -27.6% -3,881 ↓ -9.6% -9.6% -2,972 ↓ -17.5% -17.5% -2,978 ↓ -16.1% -16.1%
2019.01 2018/12/14 Q3予 1,025 → 0.0% 0.0% -3,540 → 0.0% 0.0% -2,529 → 0.0% 0.0% -2,564 → 0.0% 0.0%
2019.01 2018/09/13 Q2予 1,025 → 0.0% 0.0% -3,540 → 0.0% 0.0% -2,529 → 0.0% 0.0% -2,564 → 0.0% 0.0%
2019.01 2018/06/13 Q1予 1,025 → 0.0% 0.0% -3,540 → 0.0% 0.0% -2,529 → 0.0% 0.0% -2,564 → 0.0% 0.0%
2019.01 2018/03/13 当初予 1,025 - - - -3,540 - - - -2,529 - - - -2,564 - - -
2018.01 2018/03/13 実 490 ↓ -26.0% -26.0% -4,378 ↓ -11.0% -11.0% -3,947 ↑ +0.3% +0.3% -3,940 ↑ +1.1% +1.1%
2018.01 2017/12/13 Q3予 662 → 0.0% 0.0% -3,945 → 0.0% 0.0% -3,957 → 0.0% 0.0% -3,982 → 0.0% 0.0%
2018.01 2017/09/12 Q2予 662 → 0.0% 0.0% -3,945 → 0.0% 0.0% -3,957 → 0.0% 0.0% -3,982 → 0.0% 0.0%
2018.01 2017/06/14 Q1予 662 → 0.0% 0.0% -3,945 → 0.0% 0.0% -3,957 → 0.0% 0.0% -3,982 → 0.0% 0.0%
2018.01 2017/03/17 当初予 662 - - - -3,945 - - - -3,957 - - - -3,982 - - -
2017.01 2017/03/17 実 949 ↑ +0.2% +7.1% -1,932 ↓ -7.1% +49.3% -2,166 ↑ +5.9% +43.4% -1,835 ↑ +14.1% +49.6%
2017.01 2016/12/14 Q3予 947 ↑ +6.9% +6.9% -1,804 ↑ +52.7% +52.7% -2,301 ↑ +39.9% +39.9% -2,136 ↑ +41.3% +41.3%
2017.01 2016/06/14 Q1予 886 → 0.0% 0.0% -3,814 → 0.0% 0.0% -3,830 → 0.0% 0.0% -3,641 → 0.0% 0.0%
2017.01 2016/03/16 当初予 886 - - - -3,814 - - - -3,830 - - - -3,641 - - -
2016.01 2016/03/16 実 1,174 → 0.0% -43.4% -1,125 → 0.0% -3.1% -1,172 → 0.0% -5.7% -988 → 0.0% -7.4%
2016.01 2016/02/15 修正予 1,174 ↓ -36.0% -43.4% -1,125 ↓ -31.6% -3.1% -1,172 ↓ -39.9% -5.7% -988 ↓ -32.8% -7.4%
2016.01 2015/12/14 Q3予 1,835 → 0.0% -11.5% -855 → 0.0% +21.6% -838 ↑ +2.0% +24.4% -744 → 0.0% +19.1%
2016.01 2015/09/14 修正予 1,835 ↓ -11.5% -11.5% -855 ↑ +21.6% +21.6% -855 ↑ +22.9% +22.9% -744 ↑ +19.1% +19.1%
2016.01 2015/06/12 当初予 2,074 - - - -1,091 - - - -1,109 - - - -920 - - -
シェア ツイート
ページトップへ戻る